首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

2008076

新生牛血清市場：按產地、應用、最終用戶和地區分類

Newborn Calf Serum Market, By Origin, By Application, By End User, By Geography

出版日期: 2026年03月30日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2026年新生牛血清市場規模估計為2.899億美元，預計2033年將達到4.594億美元。預計2026年至2033年，該市場將以6.8%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	2.899億美元
業績數據週期：	2020-2024	預測期：	2026-2033
2026-2033年預測期間的複合年成長率：	6.80%	2033年市場規模預測：	4.594億美元

新生牛血清是從20日齡以下健康屠宰牛的牛中提取的液體部分，經證實適合人類食用。它廣泛應用於工業和學術研究，是細胞培養中常用的基礎培養基添加劑之一，在幹細胞研究以及獸用和人類疫苗的研發中發揮重要作用。

牛和新生牛血清通用許多相同的營養成分，但新生牛血清中白蛋白和球蛋白等蛋白質含量相對較高。 14日齡以下的健康牛在嚴格的採集和處理標準下進行檢測，用於生產新生牛血清。新生牛血清可應用於生物技術研發、幹細胞研究、克隆技術、動物診斷、體外受精、生物製藥、基因療法和合成蛋白等領域。

市場動態

市場企業間為拓展業務組合而加強合作，預計將推動全球新生牛血清市場成長。例如，2022年6月28日，醫療科技公司泰爾茂血液與細胞科技公司（Terumo Blood and Cell Technologies）與製藥公司GenCure達成合作，旨在拓展其細胞和基因療法的生產解決方案。此次合作將充分利用泰爾茂和GenCure的專業技術，在BioBridge Global建立一個參考製造地，為全球客戶提供廣泛的血液、細胞和組織產品。透過此參考生產基地，GenCure將為細胞和基因療法的研發人員提供解決方案。細胞培養技術應用於細胞和基因療法，而新生牛血清則用於培養各種細胞株。

市場相關人員正轉向先進的細胞生產技術，預計將推動全球新生牛血清市場的成長。例如，2017年，非營利組織MaRS旗下的先進治療細胞技術中心（CATCT）確定了先進的生產解決方案，以實現細胞生產流程的產業化，從而滿足全球細胞治療公司的需求。新生牛血清是Vero細胞株培養的關鍵成分，隨著細胞生產技術的進步，其使用量預計將會增加。

眾多市場參與企業積極參與各類會議，共同探討細胞株和細胞培養技術的快速發展，預計將推動全球新生牛血清市場的成長。例如，在2021年舉行的美國西部生物程序國際會議（線上舉行）上，與會者重點討論了不同培養基中細胞株的穩定性以及細胞株開發的快速成長。會議強調提高市場相關人員對細胞培養技術的認知，預計將增加牛血清在市場上的使用量。

本次調查的主要特點。

本報告對預測期（2022-2030 年）內全球新生牛血清市場規模進行了詳細分析，以 2021 年為基準年。
本報告指出了各個細分市場的潛在商機，並說明了該市場中具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要企業採取的競爭策略的重要見解。
本報告根據以下參數對全球新生牛血清市場的主要企業進行了分析：公司概況、財務表現、產品系列、地理分佈、分銷策略、關鍵發展和策略以及未來計劃。
透過利用本報告中提出的見解，企業行銷負責人和經營團隊可以就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
這份全球新生牛血清市場報告旨在為行業內的各種相關人員提供參考，包括投資者、供應商、製造商、經銷商、新參與企業和金融分析師。
透過分析全球新生牛血清市場的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 南非
- 中非
- 北非

第8章競爭情勢

公司簡介
- HiMedia Laboratories
- Thermo Fisher Scientific Inc.
- Sartorius AG
- Merck KGaA.
- Corning Inc.
- Atlas Biologicals, Inc.
- TCS Biosciences Ltd.
- Bovogen Biologicals Tty Ltd.
- Novus Biologicals, LLC
- Capricorn Scientific
- PAN-Biotech GmbH
- Atlanta Biologicals, Inc.
- Rockey Mountain Biologicals
- GE Healthcare
- Serana
- Zhejiang Tianhang Biotechnology

第9章

參考
調查方法

簡介目錄

Product Code: CMI5331

Newborn Calf Serum Market is estimated to be valued at USD 289.9 Mn in 2026 and is expected to reach USD 459.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 6.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 289.9 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.80%	2033 Value Projection:	USD 459.4 Mn

Newborn calf serum is the liquid portion of clotted blood taken from healthy, slaughtered bovine calves younger than 20 days that have been confirmed to be suitable for human consumption. It is widely used in industrial and academic research. It is one of the supplements used as a basal growth medium in cell culture. It plays a major role in stem cell research and the research of veterinary and human vaccines.

Fetal bovine serum and newborn calf serum both contain many of the same nutrients; however, newborn calf serum contains relatively more protein such as albumin and globulins. Bovine calves which are under 14 days old and healthy are inspected and collected for the production of newborn calf serum under strict collection and processing criteria. Newborn calf serum has applications in biotechnology research and development, stem cell research, cloning, animal diagnostic, in vitro fertilization, biopharmaceuticals, gene therapy, synthetic proteins, etc.

Market Dynamics

Increasing collaboration among the market players in order to expand their portfolio is expected to drive the growth of the global newborn calf serum market. For instance, in June 28, 2022, Terumo Blood and Cell Technologies, a medical technology company, collaborated with GenCure, a pharmaceutical company, to expand their manufacturing solutions for cell and gene therapy. The collaboration will utilize expertise from Terumo and GenCure to form a reference manufacturing center for BioBridge Global, provide a wide range of blood, cell and tissue products to customers worldwide. Through this reference site, GenCure will deliver solution for cell and gene therapy developers. Cell and gene therapy uses cell culture techniques and new born calf serum is used for growing different cell lines.

Market players are moving towards advance cell manufacturing technologies, which is expected to drive the global newborn calf serum market growth. For instance, in 2017, the Centre for Advanced Therapeutic Cell Technologies (CATCT) at MaRS, a nonprofit corporation found advanced manufacturing solutions to industrialize the cell manufacturing process to meet the needs of cell therapy companies around the world. Newborn calf serum is key ingredient in growing Vero cell lines, the development of cell manufacturing will increase the use of newborn calf serum.

Conferences have been organized and market players are participating on a large scale for discussion and talking about the rapid development in cell line and cell culture, which is expected to drive the global newborn calf serum market growth. For instance, in 2021, BioProcess International U.S. West conference held virtual event, highlighted its presentation on cell lines stability with different media, boom in cell-line development etc., they focused on increasing the awareness among market players about cell culture techniques, through which it is expected the use of calf serum will increase in market.

Key features of the study

This report provides an in-depth analysis of the global newborn calf serum market, market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players.
It profiles leading players in the global newborn calf serum market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
Key companies covered as a part of this study include HiMedia Laboratories, Thermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Corning Inc., Atlas Biologicals, Inc., TCS Biosciences Ltd., Bovogen Biologicals Pty Ltd., Novus Biologicals, LLC, Capricorn Scientific, PAN biotech, Atlanta Biologicals, Inc., Rockey Mountain Biologicals, GE Healthcare, Serana, and Zhejiang Tianhang Biotechnology.
Insights from this report would allow marketers and management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
The global newborn calf serum market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global newborn calf serum market

Market Segmentation

Global Newborn Calf Serum Market, By Origin
- New Zealand Origin
- U.S. Origin
- Australia Origin
- Others (Brazil Origin, Mexico Origin, etc.)
Global Newborn Calf Serum Market, By Application
- Drug Discovery
- Cell Media Culture
- Others
Global Newborn Calf Serum Market, By End User
- Biotechnology & Pharmaceutical Industries
- Academic Institutes
- Others (Research labs and Diagnostic Labs, etc.)
Global Newborn Calf Serum Market, By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Global Newborn Calf Serum Market, Key Player
- HiMedia Laboratories
- Thermo Fisher Scientific Inc.
- Sartorius AG
- Merck KGaA
- Corning Inc.
- Atlas Biologicals, Inc.
- TCS Biosciences Ltd.
- Bovogen Biologicals Pty Ltd.
- Novus Biologicals, LLC
- Capricorn Scientific
- PAN-Biotech GmbH
- Atlanta Biologicals, Inc.
- Rockey Mountain Biologicals
- GE Healthcare
- Serana
- Zhejiang Tianhang Biotechnology

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Origin
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Regulatory Scenario
PEST Analysis
Recent Product Launch/Approval
Epidemiology
Mergers and Acquisitions

4. Global Newborn Calf Serum Market, By Origin, 2026-2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
New Zealand Origin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
U.S. Origin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Australia origin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Others (Brazil Origin, Mexico Origin, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Newborn Calf Serum Market, By Application, 2026 - 2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Cell Media Culture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Newborn Calf Serum Market, By End Users, 2026 - 2033 (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Biotechnology and Pharmaceuticals industries
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Academics Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Other (Research labs and Diagnostic Labs, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

7. Global Newborn Calf Serum Market, By Region, 2026 - 2033 (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022 - 2033
- Regional Trends
North America
- Market Size and Forecast, By Origin, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Origin, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Origin, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Origin, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Origin, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033 (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Origin, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Application, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033 (USD Mn)
- Market Size and Forecast, By Country/Region , 2026 - 2033 (USD Mn)
  - South Africa
  - Central Africa
  - North Africa

8. Competitive Landscape

Company Profiles
- HiMedia Laboratories
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Thermo Fisher Scientific Inc.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Sartorius AG
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Merck KGaA.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Corning Inc.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Atlas Biologicals, Inc.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- TCS Biosciences Ltd.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Bovogen Biologicals Tty Ltd.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Novus Biologicals, LLC
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Capricorn Scientific
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- PAN-Biotech GmbH
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Atlanta Biologicals, Inc.
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Rockey Mountain Biologicals
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- GE Healthcare
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Serana
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
- Zhejiang Tianhang Biotechnology
  - Company Overview
  - Drug Portfolio
  - Financial Performance
  - Recent Developments/Updates
  - Strategies
  - Analyst Views

9. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

低血清細胞培養基市場按產品形式、細胞類型、血清濃度、應用、最終用戶和分銷管道分類，全球預測（2026-2032年）

細胞培養血清市場依產品類型、原料、應用、最終用戶及通路分類－2026-2032年全球預測

FAQ

新生牛血清市場：按產地、應用、最終用戶和地區分類

Newborn Calf Serum Market, By Origin, By Application, By End User, By Geography

市場動態

目錄

第1章：研究目標與前提條件

第2章市場概覽

第3章：市場動態、監管與趨勢分析

第4章：全球新生牛血清市場：依產地分類，2026-2033年

第5章全球新生牛血清市場：依應用領域分類，2026-2033年

第6章全球新生牛血清市場：依最終用戶分類，2026-2033年

第7章全球新生牛血清市場：依地區分類，2026-2033年

第8章競爭情勢

第9章

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Newborn Calf Serum Market, By Origin, 2026-2033 (USD Mn)

5. Global Newborn Calf Serum Market, By Application, 2026 - 2033 (USD Mn)

6. Global Newborn Calf Serum Market, By End Users, 2026 - 2033 (USD Mn)

7. Global Newborn Calf Serum Market, By Region, 2026 - 2033 (USD Mn)

8. Competitive Landscape

9. Section

新生牛血清市場：按產地、應用、最終用戶和地區分類

Newborn Calf Serum Market, By Origin, By Application, By End User, By Geography

市場動態

目錄

第1章：研究目標與前提條件

第2章 市場概覽

第3章：市場動態、監管與趨勢分析

第4章：全球新生牛血清市場：依產地分類，2026-2033年

第5章 全球新生牛血清市場：依應用領域分類，2026-2033年

第6章 全球新生牛血清市場：依最終用戶分類，2026-2033年

第7章 全球新生牛血清市場：依地區分類，2026-2033年

第8章 競爭情勢

第9章

Market Dynamics

Market Segmentation

Table of Contents

1. Research Objectives and Assumptions

2. Market Overview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Newborn Calf Serum Market, By Origin, 2026-2033 (USD Mn)

5. Global Newborn Calf Serum Market, By Application, 2026 - 2033 (USD Mn)

6. Global Newborn Calf Serum Market, By End Users, 2026 - 2033 (USD Mn)

7. Global Newborn Calf Serum Market, By Region, 2026 - 2033 (USD Mn)

8. Competitive Landscape

9. Section

第2章市場概覽

第5章全球新生牛血清市場：依應用領域分類，2026-2033年

第6章全球新生牛血清市場：依最終用戶分類，2026-2033年

第7章全球新生牛血清市場：依地區分類，2026-2033年

第8章競爭情勢